Reversal of Chronic Obstructive Pulmonary Disease-Associated Weight Loss
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 64 (10) , 1041-1052
- https://doi.org/10.2165/00003495-200464100-00002
Abstract
Poor nutritional status is associated with an increased incidence of morbidity and mortality in patients with chronic obstructive pulmonary disease (COPD). While a number of factors have been shown to produce tissue catabolism, no single mechanism has been clearly identified as a primary cause for weight loss in patients with severe COPD. Without a clear understanding of the aetiology of weight loss, therapeutic strategies to reverse this process have historically been unsuccessful. A review of recent studies allows consideration of a model of mechanisms of weight loss. This model includes multiple pathways that may be activated singly or simultaneously to cause loss of weight, specifically lean body mass. These include energy imbalances, elevated levels of cytokines, tissue hypoxia and the effects of cocorticosteroid therapy. To date, interventional studies that have looked at newer pharmacotherapies such as growth hormone and anabolic steroids in patients with COPD who arelosing weight have not demonstrated reversal of weight loss or improvement in nutritional status. Currently, early identification of patients at risk for weight loss and aggressive nutritional supplementation coupled with an exercise programme has demonstrated the greatest benefit. However, with increasing understanding of the mechanisms that may be implicated, new targets for therapies are being identified. Of particular research interest are molecules such as leukotrienes, hormones, tumour necrosis factor-α and acute-phase proteins, which are noted to be elevated in some patients with COPD-associated weight loss. Currently, inhibitors to some of these inflammatory substances are used therapeutically in other chronic illnesses such as rheumatoid arthritis and cancer cachexia. Future research may investigate their usefulness in COPD and direct new therapies that target the processes contributing to weight loss in these patients.Keywords
This publication has 67 references indexed in Scilit:
- Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndromeCritical Care Medicine, 2003
- Megestrol Acetate Stimulates Weight Gain and Ventilation in Underweight COPD PatientsChest, 2002
- Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight lossClinical Nutrition, 2000
- Critical Role of cAMP Response Element Binding Protein Expression in Hypoxia-elicited Induction of Epithelial Tumor Necrosis Factor-αJournal of Biological Chemistry, 1999
- Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung functionEuropean Journal of Clinical Nutrition, 1998
- Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.Thorax, 1996
- Hypoxia-inducible gene expressionRespiration Physiology, 1995
- Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPDEuropean Respiratory Journal, 1994
- Resting energy expenditure and nutritional state of patients with increased oxygen cost of breathing due to emphysema, scoliosis and thoracoplasty.Thorax, 1994
- Protein and Energy Metabolism with Biosynthetic Human Growth Hormone after Gastrointestinal SurgeryAnnals of Surgery, 1987